As an important part of epigenomics, DNA methylation is involved in a series of processes such as cell and tissue differentiation, development, aging and environmental adaptation, but the change of DNA methylation mode is related to multiple diseases such as cancer, mental disorder, diabetes and CVD. On basis of Illumina chip, CapitalBio Technology can offer overall solution of DNA methylation detection, to realize one-stop service that covers screening and verification.
As an economic and efficient methylation high-throughput screening technology platform, the Illumina 850K methylation microarray can realize precise detection to the methylation variation of single base. This chip is a power tool to research the complex diseases such as tumor, respiratory system, CVD and mental disease, as well as a high-throughput detection technology platform that applies to the EWAS.